| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() |
order@pharm-intermediates.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| Wuhan Sun-shine Bio-technology Corporation Limited | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (27) 6552-2453 | |||
![]() |
marketing@sun-shinechem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Shanghai Zehan Biopharma Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 6135-0663 +86 13052117465 | |||
![]() |
sales@zehanbiopharma.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2015 | ||||
| chemBlink standard supplier since 2015 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8992-5085 | |||
![]() |
sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2015 | ||||
| Classification | Biochemical >> Inhibitor >> Tyrosine protein kinase/signal transducer and transcriptional activator inhibitor (JAK/STAT) >> JAK inhibitor |
|---|---|
| Name | Pacritinib |
| Synonyms | (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene |
| Molecular Structure | ![]() |
| Molecular Formula | C28H32N4O3 |
| Molecular Weight | 472.58 |
| CAS Registry Number | 937272-79-2 |
| EC Number | 812-740-9 |
| Solubility | Insoluble (2.3E-3 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.22±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs) |
| Hazard Classification | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Pacritinib |